WO2024175631 - ORAL CARE COMPOSITION COMPRISING INVERTASE
National phase entry:
Publication Number
WO/2024/175631
Publication Date
29.08.2024
International Application No.
PCT/EP2024/054362
International Filing Date
21.02.2024
Title **
[English]
ORAL CARE COMPOSITION COMPRISING INVERTASE
[French]
COMPOSITION DE SOINS BUCCODENTAIRES COMPRENANT UNE INVERTASE
Applicants **
NOVOZYMES A/S
Krogshoejvej 36
2880 Bagsvaerd, DK
Inventors
TIWARI, Manish, Kumar
Krogshoejvej 36
2880 Bagsvaerd, DK
SEGURA, Dorotea, Raventos
Krogshoejvej 36
2880 Bagsvaerd, DK
MORANT, Marc, Dominique
Krogshoejvej 36
2880 Bagsvaerd, DK
PALMÉN, Lorena, González
Krogshoejvej 36
2880 Bagsvaerd, DK
Priority Data
23157896.4
22.02.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1696 | |
| EPO | Filing, Examination | 6194 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 6760 |
Total: 15813 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to an oral care composition comprising an invertase, use of said composition as medicaments, use of said composition in treatment of oral disease, methods of treatment comprising administering said composition to a human subject, methods of prevent- ing or removing oral biofilm comprising contacting an oral biofilm with said composition, methods for reducing the risk of oral biofilm formation, and kits of parts comprising said composition.[French]
La présente invention concerne une composition de soins buccodentiares comprenant une invertase, l'utilisation de ladite composition en tant que médicaments, l'utilisation de ladite composition dans le traitement d'une maladie buccale, des procédés de traitement comprenant l'administration de ladite composition à un sujet humain, des procédés de prévention ou d'élimination de biofilm buccal comprenant la mise en contact d'un biofilm buccal avec ladite composition, des procédés de réduction du risque de formation de biofilm buccal, et des kits comprenant ladite composition.